QUAKER CHEMICAL CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.9B | $1.8B | $2.0B | $1.9B | $1.8B |
| Cost of revenue | $1.2B | $1.2B | $1.2B | $1.3B | $1.2B |
| Gross profit | $679.4M | $686.0M | $705.6M | $612.7M | $594.6M |
| Selling, general & administrative | $502.4M | $484.8M | $483.6M | $464.2M | $418.9M |
| Research and development | $60.7M | $57.3M | $50.3M | $46.0M | $44.9M |
| Operating income | $53.0M | $194.7M | $214.5M | $52.3M | $150.5M |
| Interest expense | $44.0M | $41.0M | $50.7M | $32.6M | $22.3M |
| Pretax income | $7.0M | $155.1M | $153.1M | $7.1M | $147.0M |
| Income tax expense | $24.6M | $49.3M | $55.6M | $24.9M | $34.9M |
| Net income | -$2.5M | $116.6M | $112.7M | -$15.9M | $121.4M |
| Balance Sheet | |||||
| Cash and equivalents | $179.8M | $188.9M | $194.5M | $181.0M | $165.2M |
| Current assets | $921.2M | $876.4M | $927.9M | $994.1M | $920.3M |
| Total assets | $2.8B | $2.6B | $2.7B | $2.8B | $3.0B |
| Current liabilities | $380.2M | $379.8M | $367.5M | $354.8M | $430.5M |
| Total liabilities | $1.4B | $1.3B | $1.3B | $1.5B | $1.6B |
| Total debt | $871.2M | $708.3M | $755.6M | $954.8M | $901.3M |
| Stockholders' equity | $1.4B | $1.4B | $1.4B | $1.3B | $1.4B |
| Cash Flow Statement | |||||
| Cash from operations | $136.5M | $204.6M | $279.0M | $41.8M | $48.9M |
| Depreciation and amortization | $65.8M | $60.9M | $60.8M | $60.7M | $62.6M |
| Stock-based compensation | $13.6M | $15.0M | $14.6M | $11.7M | $11.0M |
| Capital expenditure | $55.9M | $41.8M | $38.8M | $28.5M | $21.5M |
| Free cash flow | $80.6M | $162.8M | $240.2M | $13.3M | $27.5M |
| Dividends paid | $34.4M | $33.2M | $31.6M | $30.1M | $28.6M |
| Share repurchases | $41.5M | $49.2M | $0 | $0 | — |
| Impairments | $88.8M | $0 | $0 | $93.0M | $0 |
Shares outstanding 17.4M · Free float 99.0%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.